Skip to content

Effect of Kukkkutanda Twak on Joint pains

PHARMACEUTICAL STANDARDIZATION OF KUKKUTANDA TVAK BHASMA PREPARED BY TWO DIFFERENT METHODS AND ITS EFFECT ON ASTHIKSHAYA (OSTEOPOROSIS)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/12/002262
Enrollment
18
Registered
2011-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: null- Patients suffering from Asthikshaya (osteoporosis)

Interventions

Intervention1: KTB-A: Prepares without Hingula 500 mg twice daily in capsule form after meal for 3 months with lukewarm water Control Intervention1: KTB-B: Prepared with Hingula 500 mg twice daily in

Sponsors

IPGTRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: An osteoporotic patient of either sex between 30 to 70 yrs whose BMD (t-score) is equal to or less than -1. Patients presenting with the classical symptoms of Asthikshaya vis-a-vis Osteoporosis.

Exclusion criteria

Exclusion criteria: Age below 30 and above 70 years. BMDââ?¬Ë?tââ?¬•-score above-1. Patients suffering from neoplasm of the bone. Known cases of Diabetes mellitus, uncontrolled Hypertension, Thyrotoxicosis, Hyper parathyroidism, Addisonââ?¬•s disease, Pagetââ?¬•s disease, Cushingââ?¬•s syndrome, Tuberculosis of the bone, Osteomalacia, and Chronic renal disease D, Hepatic and Cardiac failure. Rheumatoid arthritis

Design outcomes

Primary

MeasureTime frame
Observation of signs & symptoms before treatment & after treatment by scoring pattern. Serum calcium. Serum alkaline phosphates. BMD(Bone Mineral Density)(t-score, WHO- 1994) Laboratory investigations conducted before treatment & after treatment will be noted.Timepoint: 3 months

Secondary

MeasureTime frame
Exacerbation in signs and symptomsTimepoint: 15 days

Countries

India

Contacts

Public ContactDr B J Patgiri

IPGTRA

dr.krishna125@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026